Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04136340 · ClinicalTrials.gov registry record · NA

Supportive Care Delivered by Telemedicine to Cancer Patients at Home

A NA study of Cancer and Supportive Care, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT04136340 is a NA study of Cancer and Supportive Care that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 33 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04136340, a NA study of Cancer and Supportive Care, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This study will test whether supportive care follow-up delivered to cancer patients at home by telemedicine ("virtual" medical visits using telecommunications technologies) is as effective as in-person supportive care visits in the clinic.

Conditions Studied

Interventions

  • OTHER In-person in clinic follow-up visit
  • OTHER Telemedicine follow-up visit

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2019-10-24
Est. Completion 2025-07-03
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT04136340

The ClinicalTrials.gov registry entry for NCT04136340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which In-person in clinic follow-up visit is the first listed.

NCT04136340 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04136340 about?

NCT04136340 is a clinical study titled "Supportive Care Delivered by Telemedicine to Cancer Patients at Home". This study will test whether supportive care follow-up delivered to cancer patients at home by telemedicine ("virtual" medical visits using telecommunications technologies) is as effective as in-person supportive care visits in the clinic.

What is the current status of trial NCT04136340?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-10-24. Estimated completion is 2025-07-03.

What conditions does trial NCT04136340 study?

This clinical trial studies the following conditions: Cancer, Supportive Care.

What interventions are being tested in trial NCT04136340?

The interventions under investigation include: In-person in clinic follow-up visit (OTHER), Telemedicine follow-up visit (OTHER).

Who is sponsoring clinical trial NCT04136340?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04136340 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.